Save Product
Product Details
Materials Provided
IDComponentsSizeRAS177-C01Pre-coated Anti-RSV-Pre-Fusion glycoprotein F0 (site Ø) Antibody Microplate1 plateRAS177-C02Pre-Fusion glycoprotein F0 (RSV) Standard20 μgRAS177-C03HRP-Anti-RSV-Pre-Fusion glycoprotein F0 (site V) Antibody20 μgRAS177-C0410xWashing Buffer50 mLRAS177-C052xDilution Buffer50 mLRAS177-C06Substrate Solution12 mLRAS177-C07Stop Solution7 mLProduct Overview
HRSV Pre-Fusion glycoprotein F0(site Ø&V) Specific ELISA Kit is based on the sandwich-ELISA method and is used to specifically detect and quantitatively determine HRSV Pre-Fusion glycoprotein F0 (site Ø&V) in vaccine samples. The kit specifically identifies HRSV (A) and HRSV (B) Pre-Fusion glycoprotein F0, and is designed to provide a reliable solution for the manufacturing and quality control of HRSV vaccines.
Reconstitution
Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
Storage
1. Unopened kit should be stored at 2℃-8℃ upon receiving.
2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.
3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
ACRO Quality Management System
Customers Also Viewed
Performance Data
Typical Data
Please refer to DS document for the assay protocol.
For each experiment, a standard curve needs to be set for each micro-plate, and the specific OD value may vary depending on different laboratories, testers, or equipments. The following example data is for reference only.
Customer Reviews Writing Reviews
FAQ
- Product
What do “pre” and “post” refer to in the names of viral proteins?
In virology, “pre” refers to the conformation of a viral surface glycoprotein before fusion with the host cell membrane, while “post” refers to the conformation after membrane fusion and entry into the host cell. Both are naturally occurring states in the viral life cycle. Because the “pre” conformation represents a critical stage before viral entry, antibodies designed against this state often exhibit stronger neutralizing activity and are therefore more effective in preventing infection.
Contact Us
Drug Candidate Licensing
